237 related articles for article (PubMed ID: 10781394)
21. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
Hennenberg M; Trebicka J; Buecher D; Heller J; Sauerbruch T
Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
[TBL] [Abstract][Full Text] [Related]
22. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.
Ramalho LN; Ramalho FS; Zucoloto S; Castro-e-Silva Júnior O; Corrêa FM; Elias Júnior J; Magalhães JF
Hepatogastroenterology; 2002; 49(48):1499-502. PubMed ID: 12397717
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.
Zipprich A; Loureiro-Silva MR; Jain D; D'Silva I; Groszmann RJ
J Hepatol; 2008 Nov; 49(5):739-45. PubMed ID: 18804307
[TBL] [Abstract][Full Text] [Related]
24. Hepatic mitochondrial proliferation in rats with secondary biliary cirrhosis: time course and mechanisms.
Forestier M; Solioz M; Isbeki F; Talos C; Reichen J; Krähenbühl S
Hepatology; 1997 Aug; 26(2):386-91. PubMed ID: 9252149
[TBL] [Abstract][Full Text] [Related]
25. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
26. Lack of detrimental or therapeutic effects of cyclooxygenase inhibition in bile duct-ligated rats with hepatic encephalopathy.
Chan CY; Lee FY; Wang TF; Huang SW; Chang FY; Lu RH; Chen YC; Wang SS; Huang HC; Lee SD
J Gastroenterol Hepatol; 2006 Sep; 21(9):1483-7. PubMed ID: 16911697
[TBL] [Abstract][Full Text] [Related]
27. Amiloride reduces portal hypertension in rat liver cirrhosis.
Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
[TBL] [Abstract][Full Text] [Related]
28. Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats.
Rivera-Huizar S; Rincón-Sánchez AR; Covarrubias-Pinedo A; Islas-Carbajal MC; Gabriel-Ortíz G; Pedraza-Chaverrí J; Alvarez-Rodríguez A; Meza-García E; Armendáriz-Borunda J
Exp Toxicol Pathol; 2006 Nov; 58(2-3):185-95. PubMed ID: 16829063
[TBL] [Abstract][Full Text] [Related]
29. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
[TBL] [Abstract][Full Text] [Related]
30. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation.
Vázquez-Gil MJ; Mesonero MJ; Flores O; Criado M; Hidalgo F; Arévalo MA; Sánchez-Rodríguez A; Tuñón MJ; López-Novoa JM; Esteller A
Life Sci; 2004 Jun; 75(6):717-32. PubMed ID: 15172180
[TBL] [Abstract][Full Text] [Related]
31. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
32. Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents.
Monasterolo LA; Ochoa JE; Elías MM
Ren Fail; 2002 Mar; 24(2):111-26. PubMed ID: 12071586
[TBL] [Abstract][Full Text] [Related]
33. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
[TBL] [Abstract][Full Text] [Related]
34. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
35. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats.
Chuang JH; Chang NK; Huang CC; Lo SK; Wang HC; Chen CM; Wu CL; Chou MH; Lin TK
J Surg Res; 2004 Aug; 120(2):210-8. PubMed ID: 15234215
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
[TBL] [Abstract][Full Text] [Related]
37. Hypotension in experimental cirrhosis. Is loss of vascular responsiveness to norepinephrine the cause of hypotension in chronic bile-duct-ligated dogs?
Bomzon A; Binah O; Blendis LM
J Hepatol; 1993 Jan; 17(1):116-23. PubMed ID: 8445210
[TBL] [Abstract][Full Text] [Related]
38. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
39. Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis.
Weinreb M; Pollak RD; Ackerman Z
J Hepatol; 2004 Mar; 40(3):385-90. PubMed ID: 15123350
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic octreotide treatment on renal changes during cirrhosis in rats.
Jonassen TE; Christensen S; Sørensen AM; Marcussen N; Flyvbjerg A; Andreasen F; Petersen JS
Hepatology; 1999 May; 29(5):1387-95. PubMed ID: 10216120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
